Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy

Jason Wasiak


This review aims to evaluate the existing randomised controlled trials evidence on the use of botulinum toxin A in the upper limb in Cerebral palsy in order to determine the effectiveness of BtA injections on a range of pre‐defined outcomes set out by the International Classification of Functioning, Disability, and Health


Powered by

Need more features? Check out our Chrome Extension and save interactive summary cards to your Scholarcy Library.